CORONA Remedies Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Three key promoters of CORONA Remedies Limited (Dr. Kirtikumar Mehta - Chairman, Nirav Mehta - Managing Director & CEO, and Ankur Mehta - Joint Managing Director) have submitted declarations under Regulation 31(4) of SEBI SAST Regulations, 2011. Each declaration confirms that neither they nor their Persons Acting in Concert (PAC) have created any encumbrance (pledge) on the company's equity shares during FY 2025-2026. The declarations list 23 entities including family members and two LLPs (NKM Nextgen LLP and KLNext Enterprise LLP) as part of the promoter group.
This is a positive compliance disclosure indicating that promoter shareholding remains unencumbered, meaning lenders have not claimed shares as collateral. This suggests financial stability in the promoter group and removes any near-term dilution risk from forced pledge invocation.